Ulf Lindström

The lipid paradox is also present in early axial spondyloarthritis: results from the Swedish part of the SPondyloArthritis Caught Early (SPACE) cohort

Lennart T. H. Jacobsson, Helena Forsblad d'Elia, T. Husmark, J. Lopis Soler, N. Nilsson, Ulf Lindström, E. Klingberg, M. Linnerud Keshvarz, M. Rizk, P. Larsson, F. A. van Gaalen, C. Turesson, S. Exarchou
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY - 2024

Drug effectiveness of 2nd and 3rd TNF inhibitors in psoriatic arthritis – relationship with the reason for withdrawal from the previous treatment

Lykke Midtbøll Ørnbjerg, Cecilie Heegaard Brahe, Louise Linde, Lennart T. H. Jacobsson, Michael J. Nissen, Eirik Klami Kristianslund, Maria José Santos, Dan Nordström, Ziga Rotar, Bjorn Gudbjornsson, Fatos Onen, Catalin Codreanu, Ulf Lindström, Burkhard Möller, Tore K. Kvien, Anabela Barcelos, Kari K. Eklund, Matija Tomšič, Thorvardur Jon Love, Gercek Can, Ruxandra Ionescu, Anne Gitte Loft, Herman Mann, Karel Pavelka, Marleen van de Sande, I. E. van der Horst-Bruinsma, Manuel Pombo Suarez, Carlos Sánchez-Piedra, Gary J. Macfarlane, Florenzo Iannone, Brigitte Michelsen, Lise Hejl Hyldstrup, Niels Steen Krogh, Mikkel Østergaard, Merete Lund Hetland
Joint Bone Spine - 2024

Sex Differences in the Effectiveness of First-Line Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis: Results From the European Spondyloarthritis Research Collaboration Network

Pasoon Hellamand, Marleen G. H. van de Sande, Lykke M. Ornbjerg, Thomas Klausch, Kari K. Eklund, Heikki Relas, Maria J. Santos, Elsa Vieira-Sousa, Anne G. Loft, Bente Glintborg, Mikkel Ostergaard, Ulf Lindström, Johan K. Wallman, Brigitte Michelsen, Karen M. Fagerli, Isabel Castrejon, Bjorn Gudbjornsson, Thorvardur J. Love, Jiri Vencovsky, Lucie Nekvindova, Ziga Rotar, Matija Tomsic, Federico Diaz-Gonzalez, Gokce Kenar, Handan Y. Tugsal, Florenzo Iannone, Roberta Ramonda, Catalin Codreanu, Corina Mogosan, Michael J. Nissen, Burkhard Moller, Merete L. Hetland, Irene E. van der Horst-Bruinsma
ARTHRITIS & RHEUMATOLOGY - 2024

Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study

Sofia Exarchou, Daniela Di Giuseppe, Eva Klingberg, Valgerdur Sigurdardottir, Sara Wedren, Ulf Lindström, Carl Turesson, Lennart T. H. Jacobsson, Johan Askling, Johan K. Wallman
ANNALS OF THE RHEUMATIC DISEASES - 2024

Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

L. Linde, L. M. Ornbjerg, S. Georgiadis, S. H. Rasmussen, Ulf Lindström, J. Askling, B. Michelsen, D. Di Giuseppe, J. K. Wallman, B. Gudbjornsson, T. J. Love, D. C. Nordstrom, T. Yli-Kerttula, L. Nekvindova, J. Vencovsky, F. Iannone, A. Cauli, A. G. Loft, B. Glintborg, K. Laas, Z. Rotar, M. Tomsic, G. J. Macfarlane, B. Moller, M. van de Sande, C. Codreanu, M. J. Nissen, M. Birlik, S. Erten, M. J. Santos, E. Vieira-Sousa, M. L. Hetland, M. Ostergaard
Rheumatology - 2024

Validity of clinical psoriatic arthritis diagnoses made by rheumatologists in the Swedish National Patient Register

J. K. Wallman, G. M. Alenius, Eva Klingberg, V. Sigurdardottir, S. Wedren, S. Exarchou, Ulf Lindström, D. Di Giuseppe, J. Askling, Lennart T. H. Jacobsson
Scandinavian Journal of Rheumatology - 2023

Is the risk of infection higher during treatment with secukinumab than with TNF inhibitors? An observational study from the Nordic countries

B. Glintborg, D. Di Giuseppe, J. K. Wallman, S. A. Provan, D. Nordstrom, A. M. Hokkanen, J. Osterlund, E. Kristianslund, T. K. Kvien, B. Gudbjornsson, M. L. Hetland, B. Michelsen, Lennart T. H. Jacobsson, J. Askling, Ulf Lindström
Rheumatology - 2023

One-Third of European Patients With Axial Spondyloarthritis Reach Pain Remission With Routine Care Tumor Necrosis Factor Inhibitor Treatment

Lykke Midtboll Ornbjerg, Kathrine Rugbjerg, Stylianos Georgiadis, Simon Horskjaer Rasmussen, Ulf Lindström, Karel Pavelka, Neslihan Yilmaz, Ennio Giulio Favalli, Michael J. Nissen, Brigitte Michelsen, Elsa Vieira-Sousa, Gareth T. Jones, Ruxandra Ionescu, Heikki Relas, Carlos Sanchez-Piedra, Matija Tomsic, Arni Jon Geirsson, Irene van der Horst-Bruinsma, Johan Askling, Anne Gitte Loft, Lucie Nekvindova, Haner Direskeneli, Florenzo Iannone, Adrian Ciurea, Karen Minde Fagerli, Maria Jose Santos, Gary J. Macfarlane, Catalin Codreanu, Kari Eklund, Manuel Pombo-Suarez, Ziga Rotar, Bjorn Gudbjornsson, Tamara Rusman, Mikkel Ostergaard, Merete Lund Hetland
JOURNAL OF RHEUMATOLOGY - 2023

Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden.

Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Benedicte Delcoigne, Ulf Lindström, Carl Turesson, Katerina Chatzidionysiou, Elisabet Lindqvist, Ann Knight, Helena Forsblad d'Elia, Johan Askling
RMD open - 2023

Association of childhood infections and perinatal factors with ankylosing spondylitis: a Swedish nationwide case-control and sibling study

M. Morin, K. Hellgren, Ulf Lindström, T. Frisell
Rmd Open - 2023

The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017

S. Exarchou, J. K. Wallman, D. Di Giuseppe, Eva Klingberg, V. Sigurdardottir, S. Wedren, Ulf Lindström, C. Turesson, Lennart T. H. Jacobsson, J. Askling
Journal of Rheumatology - 2023

Incident gout and risk of first-time acute coronary syndrome: a prospective, population-based, cohort study in Sweden

Panagiota Drivelegka, Lennart T. H. Jacobsson, Ulf Lindström, Karin Bengtsson, Mats Dehlin
Arthritis Care and Research - 2023

Sex differences in the effectiveness of first-line tumour necrosis factor inhibitors in axial spondyloarthritis: Results from the EuroSpA Research Collaboration Network

Pasoon Hellamand, Marleen Van De Sande, Lykke Midtbøll Ørnbjerg, Thomas Klausch, Michael T. Nurmohamed, Ronald F. Van Vollenhoven, Dan Nordström, Anna Mari Hokkanen, Maria Jose Santos, Elsa Vieira-Sousa, Anne G. Loft, Bente Glintborg, Merete Lund Hetland, Ulf Lindström, Johan K. Wallman, Brigitte Michelsen, Eirik Klami Kristianslund, Adrian Ciurea, Michael S. Nissen, Catalin Codreanu, Corina Mogosan, Gary J. Macfarlane, Ovidiu Rotariu, Ziga Rotar, Matija Tomšič, Isabel Castrejon, Lucia Otero-Varela, Bjorn Gudbjornsson, Arni Jon Geirsson, Ji Vencovský, Karel Pavelka, Semih Gulle, Berrin Zengin, Florenzo Iannone, Rosario Foti, Mikkel Ostergaard, Irene Van Der Horst-Bruinsma
RMD Open - 2023

Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries

B. Glintborg, D. Di Giuseppe, J. K. Wallman, D. C. Nordstrom, B. Gudbjornsson, M. L. Hetland, J. Askling, G. Grondal, T. Sokka, S. A. Provan, B. Michelsen, E. K. Kristianslund, L. Dreyer, T. J. Love, Ulf Lindström
Annals of the Rheumatic Diseases - 2023

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study

Ulf Lindström, D. di Giuseppe, S. Exarchou, G. M. Alenius, T. Olofsson, Eva Klingberg, Lennart T. H. Jacobsson, J. Askling, J. K. Wallman
Rmd Open - 2023

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme

T. Frisell, H. Bower, M. Morin, E. Baecklund, D. Di Giuseppe, B. Delcoigne, N. Feltelius, Helena Forsblad d'Elia, E. Lindqvist, Ulf Lindström, J. Askling
Annals of the Rheumatic Diseases - 2023

Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration

L. M. Ørnbjerg, L. Linde, S. Georgiadis, S. H. Rasmussen, Ulf Lindström, J. Askling, B. Michelsen, D. D. Giuseppe, J. K. Wallman, K. Pavelka, J. Závada, M. J. Nissen, G. T. Jones, H. Relas, L. Pirilä, M. Tomšič, Z. Rotar, A. J. Geirsson, B. Gudbjornsson, E. K. Kristianslund, I. van sder Horst-Bruinsma, A. G. Loft, K. Laas, F. Iannone, A. Corrado, A. Ciurea, M. J. Santos, H. Santos, C. Codreanu, N. Akkoc, O. S. Gunduz, B. Glintborg, M. Østergaard, M. L. Hetland
Seminars in Arthritis and Rheumatism - 2022

Diagnosis, management, and outcome of cardiac sarcoidosis and giant cell myocarditis: a Swedish single center experience.

Emanuele Bobbio, Clara Hjalmarsson, Marie Björkenstam, Christian Lars Polte, Anders Oldfors, Ulf Lindström, Pia Dahlberg, Sven-Erik Bartfay, Piotr Szamlewski, Amar Taha, Egidija Sakiniene, Kristjan Karason, Niklas Bergh, Entela Bollano
BMC cardiovascular disorders - 2022

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis

M. Nissen, B. Delcoigne, D. Di Giuseppe, Lennart T. H. Jacobsson, M. L. Hetland, A. Ciurea, L. Nekvindova, F. Iannone, N. Akkoc, T. Sokka-Isler, K. M. Fagerli, M. J. Santos, C. Codreanu, M. Pombo-Suarez, Z. Rotar, B. Gudbjornsson, I. Van der Horst-Bruinsma, A. G. Loft, B. Moller, H. Mann, F. Conti, G. Y. Cetin, H. Relas, B. Michelsen, P. A. Ribeiro, R. Ionescu, C. Sanchez-Piedra, M. Tomsic, A. J. Geirsson, J. Askling, B. Glintborg, Ulf Lindström
Rheumatology - 2022

The occurrence of multiple treatment switches in axial spondyloarthritis. Results from five Nordic rheumatology registries

D. Di Giuseppe, Ulf Lindström, K. Aaltonen, H. Relas, S. Provan, B. Gudbjornsson, M. L. Hetland, J. Askling, M. Kauppi, A. J. Geirsson, K. Chatzidionysiou, T. S. Jorgensen, L. Dreyer, B. Michelsen, Lennart T. H. Jacobsson, B. Glintborg
Rheumatology - 2022

One-Year Treatment Outcomes of Secukinumab Versus Tumor Necrosis Factor Inhibitors in Spondyloarthritis: Results From Five Nordic Biologic Registries Including More Than 10,000 Treatment Courses

B. Glintborg, Ulf Lindström, D. Di Giuseppe, S. A. Provan, B. Gudbjornsson, M. L. Hetland, B. Michelsen, J. K. Wallman, K. Aaltonen, A. M. Hokkanen, D. Nordstrom, T. S. Jorgensen, R. L. Hansen, A. J. Geirsson, K. L. Gron, N. S. Krogh, J. Askling, L. E. Kristensen, Lennart T. H. Jacobsson
Arthritis Care & Research - 2022

Lifestyle Factors and Disease Activity Over Time in Early Axial Spondyloarthritis: The SPondyloArthritis Caught Early (SPACE) Cohort

S. Exarchou, C. Turesson, Ulf Lindström, R. Ramonda, R. B. Landewe, H. Dagfinrud, F. Van Gaalen, D. Van der Heijde, Lennart T. H. Jacobsson
Journal of Rheumatology - 2022

Effectiveness of baricitinib and tofacitinib compared with bDMARDs in RA: results from a cohort study using nationwide Swedish register data

A. Barbulescu, J. Askling, K. Chatzidionysiou, Helena Forsblad d'Elia, A. Kastbom, Ulf Lindström, C. Turesson, T. Frisell
Rheumatology - 2022

Is family history a predictor of response to tumour necrosis factor inhibitors in spondyloarthritis? A Swedish nationwide cohort study

M. Morin, K. Hellgren, Ulf Lindström, T. Frisell
Scandinavian Journal of Rheumatology - 2022

Comment on: Incidence of extra-articular manifestations in AS, PsA and undifferentiated SpA-results from a national register-based cohort study. Reply.

Karin Bengtsson, Helena Forsblad d'Elia, Anna Deminger, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart Jacobsson
Rheumatology (Oxford, England) - 2021

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study.

Hannah Bower, Thomas Frisell, Daniela Di Giuseppe, Bénédicte Delcoigne, Gerd-Marie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjöwall, Johan Askling
Annals of the rheumatic diseases - 2021

Incidence of extra-articular manifestations in ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis: results from a national register-based cohort study.

Karin Bengtsson, Helena Forsblad d'Elia, Anna Deminger, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart T. H. Jacobsson
Rheumatology (Oxford, England) - 2021

Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden

D. Di Giuseppe, Ulf Lindström, H. Bower, B. Delcoigne, T. Frisell, K. Chatzidionysiou, C. Sjowall, E. Lindqvist, J. Askling
Rheumatology - 2021

Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision

H. Bower, T. Frisell, D. di Giuseppe, B. Delcoigne, G. M. Ahlenius, E. Baecklund, K. Chatzidionysiou, N. Feltelius, Helena Forsblad d'Elia, A. Kastbom, L. Klareskog, E. Lindqvist, Ulf Lindström, C. Turesson, C. Sjowall, J. Askling, Artis Study Grp Artis Study Grp
Rmd Open - 2021

Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis

Ulf Lindström, B. Glintborg, D. Di Giuseppe, T. S. Jorgensen, B. Gudbjornsson, K. L. Gron, S. A. Provan, B. Michelsen, M. L. Hetland, J. K. Wallman, D. Nordstrom, N. Trokovic, T. J. Love, N. S. Krogh, J. Askling, Lennart T. H. Jacobsson, L. E. Kristensen
Rheumatology - 2021

Characteristics and outcome of a first acute myocardial infarction in patients with ankylosing spondylitis

A. Sodergren, J. Askling, Karin Bengtsson, Helena Forsblad d'Elia, T. Jernberg, Ulf Lindström, L. Ljung, A. Mantel, Lennart T. H. Jacobsson
Clinical Rheumatology - 2021

Anterior uveitis in patients with spondyloarthritis treated with secukinumab or tumour necrosis factor inhibitors in routine care: does the choice of biological therapy matter?

Ulf Lindström, Karin Bengtsson, T. Olofsson, D. Di Giuseppe, B. Glintborg, Helena Forsblad d'Elia, Lennart T. H. Jacobsson, J. Askling
Annals of the Rheumatic Diseases - 2021

Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration

Ulf Lindström, D. Di Giuseppe, B. Delcoigne, B. Glintborg, B. Möller, A. Ciurea, M. Pombo-Suarez, C. Sanchez-Piedra, K. Eklund, H. Relas, B. Gudbjornsson, T. J. Love, G. T. Jones, C. Codreanu, R. Ionescu, L. Nekvindova, J. Závada, N. Atas, S. Yolbas, K. M. Fagerli, B. Michelsen, Rotar, Rotar,, M. Tomšič, F. Iannone, M. J. Santos, P. Avila-Ribeiro, L. M. Ørnbjerg, M. Østergaard, Lennart T. H. Jacobsson, J. Askling, M. J. Nissen
Annals of the Rheumatic Diseases - 2021

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

B. Michelsen, Ulf Lindström, C. Codreanu, A. Ciurea, J. Zavada, A. G. Loft, M. Pombo-Suarez, F. Onen, T. K. Kvien, Z. Rotar, M. J. Santos, F. Iannone, A. M. Hokkanen, B. Gudbjornsson, J. Askling, R. Ionescu, M. J. Nissen, K. Pavelka, C. Sanchez-Piedra, S. Akar, J. Sexton, M. Tomsic, H. Santos, M. Sebastiani, J. Österlund, A. J. Geirsson, G. Macfarlane, I. van der Horst-Bruinsma, S. Georgiadis, C. H. Brahe, L. M. Ørnbjerg, M. L. Hetland, M. Østergaard
RMD open - 2020

Treatment retention of infliximab and etanercept originators versus their corresponding biosimilars: Nordic collaborative observational study of 2334 biologics naive patients with spondyloarthritis

Ulf Lindström, B. Glintborg, D. Di Giuseppe, D. Nordstrom, S. A. Provan, B. Gudbjornsson, J. Askling, M. L. Hetland, K. Aaltonen, N. S. Krogh, A. J. Geirsson, Lennart T. H. Jacobsson
RMD Open - 2019

Biological treatment in ankylosing spondylitis in the Nordic countries during 2010-2016: a collaboration between five biological registries

B. Glintborg, Ulf Lindström, K. Aaltonen, E. K. Kristianslund, B. Gudbjornsson, K. Chatzidionysiou, J. Askling, D. Nordstrom, M. L. Hetland, D. Di Giuseppe, L. Dreyer, L. E. Kristensen, T. S. Jorgensen, K. Eklund, G. Grondal, S. Ernestam, J. Joensuu, M. R. K. Tormanen, H. Skydsgaard, J. Hagfors, T. K. Kvien, E. Lie, K. Fagerli, A. J. Geirsson, H. Jonsson, S. A. Provan, N. S. Krogh, Lennart T. H. Jacobsson
Scandinavian Journal of Rheumatology - 2018

Uptake of rheumatology biosimilars in the absence of forced switching

D. Di Giuseppe, T. Frisell, S. Ernestam, Helena Forsblad d'Elia, E. Lindqvist, Ulf Lindström, C. Sjowall, J. Askling
Expert Opinion on Biological Therapy - 2018

Risk of cardiac rhythm disturbances and aortic regurgitation in different spondyloarthritis subtypes in comparison with general population: a register-based study from Sweden

Karin Bengtsson, Helena Forsblad d'Elia, Elisabeth Lie, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart T. H. Jacobsson
Annals of the Rheumatic Diseases - 2018

Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register

Elisabeth Lie, Ulf Lindström, Tatiana Zverkova Sandström, I. C. Olsen, H. Forsblad-d'Elia, J. Askling, M. C. Kapetanovic, L. E. Kristensen, Lennart T. H. Jacobsson
Annals of the Rheumatic Diseases - 2017

Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study

Anton J. Landgren, Lennart T. H. Jacobsson, Ulf Lindström, Tatiana Zverkova Sandström, Panagiota Drivelegka, Lena Björkman, E. Fjellstedt, Mats Dehlin
Arthritis Research & Therapy - 2017

Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.

Karin Bengtsson, Helena Forsblad d'Elia, Elisabeth Lie, Eva Klingberg, Mats Dehlin, Sofia Exarchou, Ulf Lindström, Johan Askling, Lennart T. H. Jacobsson
Arthritis research & therapy - 2017

Childhood hospitalisation with infections and later development of ankylosing spondylitis: a national case-control study

Ulf Lindström, S. Exarchou, Elisabeth Lie, Mats Dehlin, Helena Forsblad d'Elia, J. Askling, Lennart T. H. Jacobsson
Arthritis Research & Therapy - 2016

Back pain and health status in patients with clinically diagnosed ankylosing spondylitis, psoriatic arthritis and other spondyloarthritis: a cross-sectional population-based study

Ulf Lindström, A. Bremander, E. Haglund, Stefan Bergman, I. F. Petersson, Lennart T. H. Jacobsson
Bmc Musculoskeletal Disorders - 2016

Perinatal characteristics, older siblings, and risk of ankylosing spondylitis: a case-control study based on national registers

Ulf Lindström, Helena Forsblad d'Elia, J. Askling, L. E. Kristensen, Elisabeth Lie, S. Exarchou, Lennart T. H. Jacobsson
Arthritis Research & Therapy - 2016

Mortality in ankylosing spondylitis: results from a nationwide population-based study

S. Exarchou, Elisabeth Lie, Ulf Lindström, J. Askling, Helena Forsblad d'Elia, C. Turesson, L. E. Kristensen, Lennart T. H. Jacobsson
Annals of the Rheumatic Diseases - 2016

Axial spondyloarthritis - with special emphasis on prevalence, perceived health and predictors

Ulf Lindström
2016

Validity of ankylosing spondylitis and undifferentiated spondyloarthritis diagnoses in the Swedish National Patient Register

Ulf Lindström, S. Exarchou, V. Sigurdardottir, B. Sundström, J. Askling, J. K. Eriksson, Helena Forsblad d'Elia, C. Turesson, L. E. Kristensen, Lennart T. H. Jacobsson
Scandinavian Journal of Rheumatology - 2015

The prevalence of clinically diagnosed ankylosing spondylitis and its clinical manifestations: a nationwide register study

S. Exarchou, Ulf Lindström, J. Askling, J. K. Eriksson, Helena Forsblad d'Elia, M. Neovius, C. Turesson, L. E. Kristensen, Lennart T. H. Jacobsson
Arthritis Research & Therapy - 2015

Ulf Lindström

Anknuten till forskning

Publikationer